Literature DB >> 8013001

Culture systems for study of human mammary epithelial cell proliferation, differentiation and transformation.

M R Stampfer1, P Yaswen.   

Abstract

The progressive changes that occur as human epithelial cells transform to malignancy involve derangements in the normal processes of cellular proliferation and differentiation. These changes manifest in altered cell-cell and cell-basement membrane interactions. Since it is impossible to examine these events systematically as they occur in vivo, development of in vitro cell systems that can as accurately as possible reflect the in vivo state offer the next best alternative for determining the molecular mechanisms underlying human carcinogenesis. We have developed a human mammary epithelial cell system that permits long term growth of normal finite lifespan cells in a serum free medium. These cells have been transformed in vitro to immortality and malignancy. We have shown that signal transduction of the EGF receptor is essential for the normal HMEC to maintain growth. Blockage of this signal leads to a G0 arrest, and reversal of this blockage leads to a synchronous re-entry into the cell cycle. Transforming growth factor beta is a potent inhibitor of normal HMEC growth, but the transformed cell lines are capable of escaping TGFB growth inhibition while retaining physiological responses such as synthesis of extracellular matrix components. This cell system is being used to examine the differences between normal and transformed cells in expression of cell cycle and differentiation related properties. Further improvements in the cell culture system will facilitate studies on the interrelation between differentiation and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8013001

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  27 in total

Review 1.  Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype.

Authors:  K L Schmeichel; V M Weaver; M J Bissell
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

Review 2.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

3.  Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties.

Authors:  Thorarinn Gudjonsson; René Villadsen; Helga Lind Nielsen; Lone Rønnov-Jessen; Mina J Bissell; Ole William Petersen
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

4.  Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.

Authors:  M A Lynch; T A Petrel; H Song; T J Knobloch; B C Casto; D Ramljak; L M Anderson; V DeGroff; G D Stoner; R W Brueggemeier; C M Weghorst
Journal:  Gene Expr       Date:  2001

5.  p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.

Authors:  T Megha; F Ferrari; A Benvenuto; C Bellan; A V Lalinga; S Lazzi; S Bartolommei; G Cevenini; L Leoncini; P Tosi
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

Review 6.  The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis.

Authors:  Josiah Ochieng; Gladys N Nangami; Olugbemiga Ogunkua; Isabelle R Miousse; Igor Koturbash; Valerie Odero-Marah; Lisa J McCawley; Pratima Nangia-Makker; Nuzhat Ahmed; Yunus Luqmani; Zhenbang Chen; Silvana Papagerakis; Gregory T Wolf; Chenfang Dong; Binhua P Zhou; Dustin G Brown; Anna Maria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Amedeo Amedei; Rabeah Al-Temaimi; Fahd Al-Mulla; William H Bisson; Sakina E Eltom
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

7.  Improved proteome coverage by using high efficiency cysteinyl peptide enrichment: the human mammary epithelial cell proteome.

Authors:  Tao Liu; Wei-Jun Qian; Wan-Nan U Chen; Jon M Jacobs; Ronald J Moore; David J Anderson; Marina A Gritsenko; Matthew E Monroe; Brian D Thrall; David G Camp; Richard D Smith
Journal:  Proteomics       Date:  2005-04       Impact factor: 3.984

8.  Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells.

Authors:  James C Garbe; Sanchita Bhattacharya; Batul Merchant; Ekaterina Bassett; Karen Swisshelm; Heidi S Feiler; Andrew J Wyrobek; Martha R Stampfer
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

9.  Multiple mechanisms are responsible for transactivation of the epidermal growth factor receptor in mammary epithelial cells.

Authors:  Karin D Rodland; Nikki Bollinger; Danielle Ippolito; Lee K Opresko; Robert J Coffey; Richard Zangar; H Steven Wiley
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

10.  An extensive survey of tyrosine phosphorylation revealing new sites in human mammary epithelial cells.

Authors:  Tyler H Heibeck; Shi-Jian Ding; Lee K Opresko; Rui Zhao; Athena A Schepmoes; Feng Yang; Aleksey V Tolmachev; Matthew E Monroe; David G Camp; Richard D Smith; H Steven Wiley; Wei-Jun Qian
Journal:  J Proteome Res       Date:  2009-08       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.